We used stable-isotope-labelled amino acids to measure the effects of alcoholic liver disease (ALD) on whole-body protein turnover and small-intestinal mucosal protein synthesis. Groups comprising eight patients with ALD and eight healthy control subjects were studied. They received primed, continuous intravenous infusions of L-[1-
INTRODUCTION
Malnutrition is commonly associated with alcoholism [1, 2] . By the time patients have developed liver disease which is clinically obvious, they often show evidence of protein\energy malnutrition [3, 4] and other nutritional deficiencies [5] . There is some difficulty in accurately defining the nutritional status in chronic alcoholism [6] . Among the methods used are measurement of nitrogen status and metabolism by such indices as the ratio of concentrations of branched-chain to aromatic amino acids in plasma, and the rate of plasma amino acid turnover obtained using labelled leucine [1] . There is evidence of wasting of lean body mass in alcoholic liver disease (ALD), especially of skeletal muscle [7] , but little is known about the involvement of the gut in the wasting process. Studies in rats have provided evidence of depressed small-intestinal mucosal protein synthesis [8] [9] [10] in response to alcohol, suggesting the existence of similar deficits in humans. Furthermore, little is known about the functional correlates of possible gastrointestinal involvement in humans in response to chronic ethanol ingestion.
The aims of the present study were : (1) to measure indices of mucosal cell size and protein synthetic capacity and the rate of small-intestinal mucosal protein synthesis, and (2) to investigate links between protein turnover in the gut and that in the whole body in patients with ALD and in normal healthy subjects.
METHODS

Patients and normal controls
Eight patients with ALD were studied at the Department of Gastroenterology, Glasgow Royal Infirmary (Table  1) . Each subject gave written consent after a full explanation of the nature of the study. Approval was obtained from the Ethics Committee of Glasgow Royal Infirmary University NHS Trust. The results from those patients with ALD were compared with results obtained from a group of eight normal healthy subjects (age 44p15 years ; weight 71p12 kg ; height 171p11 cm) who consumed less than 10 units of alcohol weekly and had normal liver function tests. The results from the patients were compared with results from the normal (Table 2) . Patients with infection, encephalopathy, gastrointestinal bleeding, uncorrected coagulation status or any previous history of hepatic failure were excluded from the study. All patients were studied within 1 week of admission. All patients showed clinical, biochemical and ultrasonic evidence of parenchymal liver damage (Table 3 ). Liver biopsy in two patients confirmed the diagnosis of ALD, and in one of them fell just short of a diagnosis of hepatic cirrhosis. Screening for autoimmune [anti-(smooth muscle) antibodies, anti-mitochondrial antibodies and anti-nuclear factor] and viral (hepatitis A, B and C) factors was negative in all patients. None of the patients were taking drugs that could affect the liver, apart from alcohol. All patients were started on a daily diet restricting sodium (to 40 mmol) and water (to 1 litre) with a normal protein intake (100 g) on admission to hospital. They were also started on spironolactone (Aldactone ; Searle), 100-200 mg daily, to control their fluid retention.
To gain an insight into the severity of ALD in the Small-bowel protein turnover in alcoholism (Table 4) . We used this scoring system to correlate the severity of ALD with the small-intestinal mucosal protein synthetic rate and whole-body protein turnover. The serum vitamin B "# concentration was found to be a useful marker for the severity of necrosis observed in liver biopsy [11] . 
Experimental design
The subjects were studied in the morning after an overnight fast. Priming doses of L-[1-"$C]leucine (1 mg\ kg body weight in 0.9 % NaCl) were given intravenously over 1 min ; a constant infusion of the same tracer at a rate of 1 mg:h −" :kg −" body weight was then continued at 1 ml\min for 4 h. After 240 min of continuous infusion, upper-gastrointestinal endoscopy was performed, and multiple (up to five) distal duodenal biopsies were obtained. The range of the pooled wet weight of biopsies was 56-88 mg. A further single biopsy was taken from each patient for histology. Venous blood samples were taken at k15, 0, 60, 120, 180 and 240 min. Further blood samples were obtained during the first 2 h at 10 min intervals to measure absorption. Venous blood samples were centrifuged (3000 g, 15 min) and the separated plasma was stored in liquid nitrogen until analysis.
Analysis
The labelling and concentrations of plasma and tissue free leucine, α-oxoisocaproate and phenylalanine were measured by standard gas chromatography MS techniques using t-butyldimethylsilyl derivatives [12] . Mucosal tissue samples were frozen in liquid nitrogen immediately on sampling, and samples were pooled for storage at k70 mC. The pooled mucosal tissue samples were ana-lysed for concentrations of protein, RNA and DNA [13] , and for the labelling of free tissue leucine as a surrogate measure of the labelling of the leucyl-tRNA pool [14] .
The labelling with "$C of leucine in hydrolysed protein was measured by using preparative gas chromatography to isolate the amino acid, with isotope-ratio MS of the CO # liberated by ninhydrin [15] . Plasma protein from the pre-infusion samples was used to estimate basal body protein "$C labelling, to allow determination of the amount of label incorporated into tissue protein, for use in the calculation of the mucosal protein synthetic rate.
Calculations and statistical analysis
Protein synthesis was calculated as a fractional rate using the equation :
where E t is the enrichment in tissue protein at time t, E ! is the baseline enrichment and E p is the enrichment of the precursor, which in this case we took to be intracellular free leucine. This calculation depends on the assumption that incorporation of the tracer into the protein is linear, a fact that we have demonstrated previously for normal control subjects [14] .
Whole-body protein breakdown (i.e. the rate of dilution of tracer leucine, otherwise known as the rate of appearance of leucine or the rate of whole-body protein turnover), was calculated using the equation ;
Protein breakdown (µmol of leucine:h −" :kg −" )
where i is the rate of leucine infusion and E KIC is the enrichment of the oxo acid of leucine [16] . The leucine tracer is transaminated in muscle, the largest tissue in the body, and thus the enrichment of its oxo acid is a reasonable measure of the extent of dilution of leucine tracer with unlabelled leucine appearing from protein breakdown.
Values are expressed as meanpS.D. and mean (range). Statistical analysis used the unpaired Student t test, Spearman's rank correlation test or the two-tailed t test as appropriate. Differences were considered significant at P values of 0.05.
RESULTS
A plateau level of 5.1p0.75 atom % excess of L- [1- "$C]leucine enrichment was achieved within 1 h of infusion, and this remained unchanged throughout the remainder of the infusion period until biopsies were obtained at endoscopy.
The distal duodenal mucosal protein synthesis rate was found to be lower in the ALD patients than in the control subjects (2.04p0.18 and 2.58p0.32 %:h −" respectively ; P 0.003) (Figure 1) .
The protein\DNA ratio, an index of cell size, was also lower in the patients with ALD than in the control subjects (9.2p0.9 and 13.0p2.2 mg\µg respectively ; P 0.002) (Figure 2) . The RNA\protein ratio, an index of the protein synthetic capacity of the tissue, was higher in the ALD patients than in the control subjects (160.3p 14.0 and 137.1p5.7 µg\mg respectively ; P 0.003) (Figure 2) .
Mean values of whole-body protein breakdown (or turnover, or rate of appearance of leucine) in the ALD patients and control subjects were statistically indistinguishable (204p18 and 196p44 µmol of leucine:h −" :kg −" respectively).
The concentration of leucine (a branched-chain amino acid) was significantly lower in ALD patients than in the control subjects (96p16 mmol\l and 132p26 mmol\l respectively), and the concentration of the aromatic amino acid phenylalanine was significantly higher in ALD patients than in the control subjects (71p7 and 56p5 µmol\l respectively). Thus the leucine\phenyl-alanine concentration ratio was significantly lower in the Small-bowel protein turnover in alcoholism The severity of ALD in the patients studied was moderate, with a mean value of 8.4 (range 5-13) on a scale of 0-18. The severity of ALD was correlated positively with whole-body protein turnover (y l 119j9.7x ; r l 0.88, P 0.01) ( Figure 3 ) and negatively with the smallintestinal mucosal protein synthesis rate (y l 267k 0.70x ; r l 0.72, P 0.05) (Figure 4) . No correlation was found with reported alcohol consumption (either weekly or cumulative).
DISCUSSION
The results of the present study show that, in patients with ALD, small-intestinal mucosal protein synthesis was depressed by 21 % ; this depression was, paradoxically, accompanied by a 16 % increase in the protein synthetic capacity of the intestinal mucosa. The mean rates of whole-body protein turnover were not different between the two groups. However, in the ALD patients there was an inverse relationship between rate of smallintestinal mucosal protein synthesis and the severity of ALD, and a direct relationship between the latter and the rates of whole-body protein synthesis and breakdown.
Previous work on liver cirrhosis suggested a depression of protein synthesis in another tissue, skeletal muscle, accompanied by an overall fall in whole-body protein turnover [17] . However, whole-body protein turnover has also been reported to be higher in patients than in normal control subjects [7] . The extent and direction of the alteration in whole-body protein turnover may depend on the severity of liver disease [18] . The present results show clearly a direct relationship between the rate of whole-body protein turnover and the severity of liver disease. Increasing severity of ALD was also closely correlated with a reduction in the rate of small-intestinal protein synthesis. The reduced protein\DNA ratio in ALD patients suggests a smaller size of the mucosal cells, or simply a reduced protein content of the intestinal mucosal tissue as part of the general reduction in the total lean body mass. Patients with significant ALD tend to have a lower protein intake than usual [19] , and this poor dietary intake is probably responsible for the alteration in lean body mass and fat stores observed in these subjects [11] . The extent to which this caused the depression in mucosal protein synthetic activity can only be guessed at. The apparent increase in the protein synthetic capacity (i.e. RNA\protein ratio) may have been an artefact, simply reflecting the loss of mucosal protein.
The extent to which changes in duodenal mucosal cell protein turnover reflect other cell functions is speculative. The amino acid concentrations in our patients, and particularly the depressed branched-chain\aromatic amino acid ratio, are in keeping with previous reports [20] [21] [22] . In the rat, alcohol ingestion can induce defects in the intestinal transport of various amino acids, e.g. phenylalanine, leucine, glycine, alanine, methionine and valine [23, 24] . These defects might alter the concentrations of various amino acids, in addition to any alterations in liver amino acid metabolism ; however, since alcohol depresses the transport of both leucine and phenylalanine, this cannot explain the altered concentration ratio between these two amino acids in the plasma. Our previous work suggested that, in alcoholic patients, functional impairment of water and electrolyte absorption can be observed, without any associated changes in small-bowel mucosal histology [25] .
Studies in animals have suggested a direct damaging effect of alcohol on the intestinal mucosa, causing atrophy or shortening of the intestinal villi [26] . In the present study no abnormality was detected in small-bowel mucosal histology. Furthermore, we have found in other studies that mucosal villous atrophy is associated with elevated, rather than reduced, rates of mucosal protein synthesis [27] .
It remains to be established whether the reduced rate of small-intestinal mucosal protein synthesis we have found in patients with ALD is related to poor dietary intake, a direct effect of alcohol, or some indirect effect due to altered liver metabolism.
